Delivery of individual elements of the discharge bundle at level 2 comparator and implementation sites
| Discharge bundle | ||||
| Bundle element | Delivery | Comparator sites, n (%) | Implementation sites, n (%) | P value |
| 1. Assess respiratory medications and inhaler technique. | ||||
| 1a. Respiratory medications. | Yes | 342 (53.4) | 542 (68.5) | <0.001 |
| 1b. Inhaler technique. | Yes | 106 (17.1) | 307 (40.4) | <0.001 |
| 1a and 1b | Yes | 102 (16.1) | 302 (39.4) | <0.001 |
| 2. All patients should receive | ||||
| 2a. Written pack about managing further AECOPD. | Yes/not applicable | 253 (39.6) | 404 (51.5) | <0.001 |
| 2b. Discharge pack of emergency medications. | Yes/not applicable | 170 (26.4) | 573 (73.6) | <0.001 |
| 2a and 2b | Yes | 133 (20.6) | 352 (45.3) | <0.001 |
| 3. Assess smoking status and willingness to quit. | ||||
| Smoker but cessation not discussed | 124 (23.4) | 102 (14.4) | <0.001 | |
| Smoker/ex-smoker and cessation discussed | 68 (12.8) | 173 (24.4) | ||
| Never smoker/ex-smoker | 338 (63.8) | 435 (61.3) | ||
| 4. Assess for suitability of pulmonary rehabilitation prior to discharge. | ||||
| Yes/completed rehab previously/declined or not applicable | 172 (26.4) | 407 (51.6) | <0.001 | |
| 5. Organise community follow-up within 2 weeks of discharge from hospital. | ||||
| Yes, declined or not applicable | 356 (54.9) | 555 (70.3) | <0.001 | |
AECOPD, acute exacerbation of chronic obstructive pulmonary disease.